Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dryopteris juxtapostia shoot methanol extract is a natural product research compound derived from the shoots of the fern *Dryopteris juxtapostia*, a species native to Pakistan and Kashmir. The extract is a complex mixture of phytochemicals, including flavonoids such as kaempferol, catechin, and epicatechin, as well as organic acids like quinic acid and various phloroglucinol derivatives (e.g., albaspidin PP, flavaspidic acids, and filixic acids). While members of the *Dryopteris* genus are often investigated for their biological potential, preclinical studies conducted by academic researchers in Pakistan found that the shoot methanol extract of *D. juxtapostia* exhibited negligible activity in antioxidant, anti-inflammatory, and cytotoxic assays compared to root-derived extracts. Due to this lack of significant biological influence, the shoot methanol extract was not selected for further hepatoprotective studies. It remains an academic research tool rather than a candidate for pharmaceutical development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dryopteris juxtapostia shoot methanol extract.